Medifast (NYSE:MED) Issues Earnings Results

Medifast (NYSE:MED) released its quarterly earnings data on Tuesday. The specialty retailer reported $0.10 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.26, Zacks reports. Medifast had a return on equity of 15.98% and a net margin of 1.09%. Medifast updated its Q1 2025 guidance to -0.500-0.000 EPS.

Medifast Price Performance

Medifast stock traded down $0.16 during trading hours on Tuesday, hitting $16.05. 280,528 shares of the stock were exchanged, compared to its average volume of 212,304. The stock has a market capitalization of $175.55 million, a P/E ratio of 24.32 and a beta of 1.14. The business’s 50-day moving average is $16.61 and its two-hundred day moving average is $18.05. The company has a debt-to-equity ratio of 0.06, a quick ratio of 2.55 and a current ratio of 3.11. Medifast has a 12 month low of $14.76 and a 12 month high of $49.90.

Wall Street Analyst Weigh In

Separately, DA Davidson upgraded Medifast from an “underperform” rating to a “neutral” rating and increased their price objective for the stock from $16.50 to $17.00 in a research note on Tuesday, November 5th.

Medifast Company Profile

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.